Sharecast
  • uk
    uk United Kingdom
    it Italian
    es Spanish
    pt Portuguese
    fr French
    de German
    zh-CN Chinese (Sim.)
    zh-TW Chinese (Tra.)
    ru Russian
    da Danish
    hr Croatian
    nl Dutch
    fi Finnish
    ja Japanese
    sv Swedish
    no Norwegian
    pl Polish
    ro Romanian
    sr Serbian
    tr Turkish
    id Indonesian
    bs Bosnian
    bg Bulgarian
    ca Catalan
    cs Czech
    el Greek
    af Afrikaans
    sq Albanian
    am Amharic
    ar Arabic
    hy Armenian
    az Azerbaijani
    eu Basque
    be Belarusian
    bn Bengali
    ceb Cebuano
    ny Chichewa
    co Corsican
sharecast

Profile

  • Overview
  • Profile data
    • Overview
    • Profile data
  • Home
  • UK Shares
      UK SHARES
    • Home
    • Results
    • Broker Views
    • Director Dealings
    • IPO Centre
    • Company Diary
    • Regulatory News
    • Company A-Z
  • Market Data
      MARKET DATA
    • Overview
    • Indices
    • Currencies
    • Commodities
    • Gilts
    • ETFS
    • Bonds
  • Sharecast News
  • Cryptocurrencies
  • Technical Analysis
  • Active Trader
  • Funds
      FUNDS
    • Funds Centre
    • Managers
    • News
  • Brokers
      BROKERS
    • Home
    • Forex
    • Shares
    • Binary Options
    • CFDs
    • Futures
    • Options
    • Spread Betting
  • Learn on finance
  • Spread Bet
      SPREAD BET
    • Learn
    • Strategies
  • Economic calendar
  • Portfolio
  • Watchlist
  •  More
    • Home
    • UK Shares
      • Home
      • Results
      • Broker Views
      • Director Dealings
      • IPO Centre
      • Company Diary
      • Regulatory News
      • Company A-Z
    • Market Data
      • Overview
      • Indices
      • Currencies
      • Commodities
      • Gilts
      • ETFS
      • Bonds
    • Sharecast News
    • Cryptocurrencies
    • Technical Analysis
    • Active Trader
    • Funds
      • Funds Centre
      • Managers
      • News
    • Brokers
      • Home
      • Forex
      • Shares
      • Binary Options
      • CFDs
      • Futures
      • Options
      • Spread Betting
    • Learn on finance
    • Spread Bet
      • Learn
      • Strategies
    • Economic calendar
    • Portfolio
    • Watchlist
  • Sector
  • Pharma and Biotech
  • Indices
  • FTSE AIM

Allergy Therapeutics (AGY)

7.15p

16:55 22/05/25

  • 2.14% 0.15p
  • Today's Low & High
  • 6.71 / 7.20
  • Open / Previous Close
  • 7.00 / 7.15
  • 52-week range
  • 116.67% 3.85p
  • Volume
  • 256,802
  • Market Cap(million)
  • £340.80m
Advertising
  • Summary
  • Profile
  • Share Prices
  • Financials
  • News
  • Charts
  • Director Deals
  • Broker Views
  • Star Ratings

Profile

  • Overview
  • Profile data

Allergy Therapeutics - Overview

We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.

Registrars:

Key Personnel

CEO: Manuel Llobet
Non-Executive Director: Anthony Parker , Zheqing Shen , Cheryl MacDiarmid, David Ball
Non-Executive Chairman: Peter Jensen
Chief Finance Officer: Shaun Furlong
Independent Non-Executive Director: Tunde Otulana

Contact Details

Address: Dominion Way, Worthing, West Sussex, United Kingdom
Phone: +44 (0) 1903 844 700
Fax: +44 (0) 1903 844 726
Website: http://www.allergytherapeutics.com/
Email:

Listings

ISIN: GB00B02LCQ05
Sector: Pharma and Biotech, Pharma and Biotech
Main Indices: FTSE AIM All-Share

Allergy Therapeutics Market Data

Currency UK Pounds
Share Price 7.15p
Time 16:55 22/05/25
Change Today 0.15p
% Change 2.14%
Volume 256,802
High 52 week range 7.70p
Low 52 week range 3.40p
Shares Issued 4,766.44m
Market Cap(million) £340.80m
Beta 0.03
RiskGrade n/a

Allergy Therapeutics Dividend data

LatestPrevious
InterimInterim
Ex-Divn/an/a
Paidn/an/a
Amount0.00p0.00p

Historic Charts

  • 1m
  • 6m
  • 1y
vs. Market
vs. Sector
Much worse than compared
Worse than compared
Equal then compared
Better then compared
Much better then compared

Allergy Therapeutics
Start Ratings

Growth

  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Income

Not Available

Price Trend

  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Value

  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 0
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
  • Latest recommendations
  • Broker consensus analysis
Loading:
  • About us
  • Advertising
  • Terms & Conditions
  • Privacy policy
  • Cookies
  • Contact
Back to the top

2025 © Sharecast.com. All rights reserved.

Login with Facebook
Login with Google
o
Forgot password?
Don’t have an account? Sign In